A Case of Delayed Risperidone-induced Neuroleptic Malignant Syndrome.
- Author:
Heon Jeong LEE
1
;
Bang Hyun CHO
;
Leen KIM
;
Min Soo LEE
Author Information
1. Department of Neuropsychiatry, Korea University College of Medicine, Seoul, Korea.
- Publication Type:Case Report
- Keywords:
Risperidone;
Neuroleptic malignant syndrome
- MeSH:
Humans;
Korea;
Male;
Movement Disorders;
Neuroleptic Malignant Syndrome*;
Receptors, Serotonin, 5-HT2;
Risperidone;
Schizophrenia
- From:Journal of Korean Neuropsychiatric Association
1999;38(4):904-908
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Risperidone is a relatively new antipsychotic agent. It is often referred to as 'atypical', because it has a mechanism of action that blocks post synaptic dopamine-2 and serotonin-2 receptors, it is associated with fewer extrapyramidal side effects, it is not yet associated with tardive dyskinesia, and it may have some efficacy on negative symptoms of schizophrenia. In despite of its 'atypical' nature, there are already more than 15 reports of risperidone-induced neuroleptic malignant syndrome. Only one case of risperidone-induced NMS was reported recently in Korea. We report one case of delayed risperidoneinduced neuroleptic malignant syndrome in young male patient and review the related articles.
